• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者的肺癌

Lung cancer in the elderly patient.

作者信息

Lee-Chiong T L, Matthay R A

机构信息

Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.

出版信息

Clin Chest Med. 1993 Sep;14(3):453-78.

PMID:8222563
Abstract

One half of all cases of lung cancer occur in patients aged 65 years and older. Although adenocarcinoma is the predominant histologic subtype in the general population, squamous cell carcinoma has remained the most common type in the elderly. Although lung cancer tends to present at a less advanced stage with increasing age, the percentage of elderly patients undergoing treatment tends to decline despite the fact that they can tolerate the aggressive therapy that may enhance survival.

摘要

所有肺癌病例中有一半发生在65岁及以上的患者中。尽管腺癌是普通人群中主要的组织学亚型,但鳞状细胞癌在老年人中仍然是最常见的类型。虽然肺癌往往随着年龄增长在较晚阶段出现,但尽管老年患者能够耐受可能提高生存率的积极治疗,但接受治疗的老年患者比例却趋于下降。

相似文献

1
Lung cancer in the elderly patient.老年患者的肺癌
Clin Chest Med. 1993 Sep;14(3):453-78.
2
Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.台湾肺癌患者按组织学类型、性别和年龄组划分的分布及转归情况。
Cancer. 2005 Jun 15;103(12):2566-74. doi: 10.1002/cncr.21087.
3
Updates in non-small cell lung cancer.非小细胞肺癌的最新进展
Clin J Oncol Nurs. 2008 Aug;12(4):587-96. doi: 10.1188/08.CJON.587-596.
4
Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.泰国乌汶叻差他尼癌症中心晚期非小细胞肺癌患者的生存情况。
Southeast Asian J Trop Med Public Health. 2005 Jul;36(4):994-1006.
5
The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.血清铁蛋白浓度是原发性肺癌患者生存的重要预后指标。
Oncol Rep. 2002 Jan-Feb;9(1):193-8.
6
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.年龄和合并症作为非小细胞肺癌治疗中的独立预后因素:加拿大国立癌症研究所临床试验组试验综述
J Clin Oncol. 2008 Jan 1;26(1):54-9. doi: 10.1200/JCO.2007.12.8322.
7
Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.卡铂联合口服依托泊苷用于老年晚期非小细胞肺癌患者:一项II期研究
Anticancer Res. 1997 Nov-Dec;17(6D):4755-8.
8
Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.组织学类型和吸烟状态对非小细胞肺癌血清癌胚抗原值解读的影响。
Ann Thorac Surg. 2004 Sep;78(3):1004-9; discussion 1009-10. doi: 10.1016/j.athoracsur.2004.03.019.
9
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.两种常用于局部晚期III期非小细胞肺癌的新辅助放化疗方案:长期结果及与病理反应的关联
J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13. doi: 10.1016/j.jtcvs.2003.07.027.
10
Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.老年患者的肺癌:监测、流行病学和最终结果数据库分析
J Clin Oncol. 2007 Dec 10;25(35):5570-7. doi: 10.1200/JCO.2007.12.5435.

引用本文的文献

1
Lung Cancer: New Directions in Senior Patients Assessment.肺癌:老年患者评估的新方向
Geriatrics (Basel). 2024 Aug 1;9(4):101. doi: 10.3390/geriatrics9040101.
2
Computed Tomography-Guided Percutaneous Radiofrequency Ablation in Older Adults With Early-Stage Peripheral Lung Cancer: A Retrospective Cohort Study.计算机断层扫描引导经皮射频消融治疗老年早期周围型肺癌:一项回顾性队列研究。
Cancer Control. 2022 Jan-Dec;29:10732748211070702. doi: 10.1177/10732748211070702.
3
Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.
台湾全民健康保险制度下肺癌患者拒绝治疗的相关因素及其生存情况:一项全国队列研究
PLoS One. 2014 Jul 7;9(7):e101731. doi: 10.1371/journal.pone.0101731. eCollection 2014.
4
Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group study.在日本长野肺癌研究组的研究中,对接受吉非替尼作为一线治疗的老年表皮生长因子受体突变型非小细胞肺癌患者的临床结局进行回顾性分析。
Med Oncol. 2013 Mar;30(1):450. doi: 10.1007/s12032-012-0450-2. Epub 2013 Jan 13.
5
Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.贝伐单抗:其在非小细胞肺癌治疗中临床潜力的证据
Core Evid. 2007 Mar 31;2(1):31-49.
6
Outcome of surgery for lung cancer in young and elderly patients.
Surg Today. 2005;35(10):823-7. doi: 10.1007/s00595-004-3035-7.
7
Age and the treatment of lung cancer.年龄与肺癌的治疗
Thorax. 1996 Jun;51(6):564-8. doi: 10.1136/thx.51.6.564.